rituximab

Ligand id: 6780

Name: rituximab

Classification
Compound class Antibody
Approved drug? Yes (source: FDA (1997), EMA (1998))
International Nonproprietary Names
INN number INN
7609 rituximab
Synonyms
HSDB 7455
MabThera®
Rituxan®
Database Links
Specialist databases
IMGT/mAb-DB 161
Other databases
PubChem SID 178103386
Search PubMed clinical trials rituximab
Search PubMed titles rituximab
Search PubMed titles/abstracts rituximab
Wikipedia Rituximab
Comments
Rituximab is a type I anti-CD20 monoclonal, designed to target surface CD20 on B-lymphocytes.
Annotated peptide sequences for this antibody are available from its IMGT/mAb-DB record.
Biosimilar PF-05280586 is in development [6] (evaluated in clinical trial NCT01526057).